Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 25% ± 8% | |
astrocyte | 8 studies | 32% ± 12% | |
microglial cell | 7 studies | 24% ± 8% | |
oligodendrocyte | 7 studies | 24% ± 8% | |
epithelial cell | 6 studies | 32% ± 13% | |
oligodendrocyte precursor cell | 6 studies | 27% ± 11% | |
lymphocyte | 4 studies | 16% ± 0% | |
GABAergic neuron | 4 studies | 35% ± 10% | |
macrophage | 4 studies | 21% ± 3% | |
myeloid cell | 3 studies | 18% ± 2% | |
basal cell | 3 studies | 25% ± 7% | |
glutamatergic neuron | 3 studies | 48% ± 11% | |
goblet cell | 3 studies | 29% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 34% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 6380.71 | 245 / 245 | 100% | 26.56 | 502 / 502 |
thymus | 100% | 6590.42 | 653 / 653 | 100% | 21.46 | 604 / 605 |
lung | 100% | 5496.63 | 578 / 578 | 100% | 15.17 | 1153 / 1155 |
ovary | 100% | 6818.52 | 180 / 180 | 100% | 13.56 | 429 / 430 |
breast | 100% | 5956.59 | 459 / 459 | 100% | 18.46 | 1113 / 1118 |
brain | 99% | 3244.40 | 2628 / 2642 | 100% | 20.16 | 705 / 705 |
kidney | 100% | 3980.03 | 89 / 89 | 99% | 16.40 | 895 / 901 |
bladder | 100% | 6002.24 | 21 / 21 | 99% | 12.60 | 500 / 504 |
liver | 100% | 3054.98 | 226 / 226 | 99% | 10.87 | 401 / 406 |
pancreas | 100% | 3213.16 | 328 / 328 | 98% | 12.54 | 175 / 178 |
uterus | 100% | 7204.29 | 170 / 170 | 98% | 16.09 | 450 / 459 |
esophagus | 100% | 5421.74 | 1445 / 1445 | 97% | 12.76 | 178 / 183 |
intestine | 100% | 6056.82 | 966 / 966 | 97% | 10.87 | 511 / 527 |
stomach | 100% | 4304.83 | 359 / 359 | 97% | 10.84 | 277 / 286 |
skin | 100% | 5081.32 | 1809 / 1809 | 96% | 14.86 | 452 / 472 |
adrenal gland | 100% | 4270.15 | 258 / 258 | 94% | 12.02 | 216 / 230 |
adipose | 100% | 5729.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5811.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.24 | 29 / 29 |
muscle | 100% | 6052.89 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4729.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.76 | 45 / 45 |
heart | 99% | 3361.56 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 10.22 | 74 / 80 |
peripheral blood | 82% | 2118.30 | 760 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0008283 | Biological process | cell population proliferation |
GO_0001541 | Biological process | ovarian follicle development |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0071559 | Biological process | response to transforming growth factor beta |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0060395 | Biological process | SMAD protein signal transduction |
GO_0003220 | Biological process | left ventricular cardiac muscle tissue morphogenesis |
GO_0001666 | Biological process | response to hypoxia |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0014033 | Biological process | neural crest cell differentiation |
GO_0048589 | Biological process | developmental growth |
GO_0048733 | Biological process | sebaceous gland development |
GO_0032909 | Biological process | regulation of transforming growth factor beta2 production |
GO_0033686 | Biological process | positive regulation of luteinizing hormone secretion |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0003161 | Biological process | cardiac conduction system development |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0003190 | Biological process | atrioventricular valve formation |
GO_0071773 | Biological process | cellular response to BMP stimulus |
GO_0001701 | Biological process | in utero embryonic development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0048665 | Biological process | neuron fate specification |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_0072520 | Biological process | seminiferous tubule development |
GO_1901203 | Biological process | positive regulation of extracellular matrix assembly |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0003251 | Biological process | positive regulation of cell proliferation involved in heart valve morphogenesis |
GO_0030325 | Biological process | adrenal gland development |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0036302 | Biological process | atrioventricular canal development |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0046881 | Biological process | positive regulation of follicle-stimulating hormone secretion |
GO_0061040 | Biological process | female gonad morphogenesis |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0003198 | Biological process | epithelial to mesenchymal transition involved in endocardial cushion formation |
GO_0003148 | Biological process | outflow tract septum morphogenesis |
GO_0072134 | Biological process | nephrogenic mesenchyme morphogenesis |
GO_0014898 | Biological process | cardiac muscle hypertrophy in response to stress |
GO_0010631 | Biological process | epithelial cell migration |
GO_0032525 | Biological process | somite rostral/caudal axis specification |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0042118 | Biological process | endothelial cell activation |
GO_0048382 | Biological process | mesendoderm development |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0060065 | Biological process | uterus development |
GO_0051797 | Biological process | regulation of hair follicle development |
GO_1905305 | Biological process | negative regulation of cardiac myofibril assembly |
GO_0007338 | Biological process | single fertilization |
GO_0048859 | Biological process | formation of anatomical boundary |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0010614 | Biological process | negative regulation of cardiac muscle hypertrophy |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001702 | Biological process | gastrulation with mouth forming second |
GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
GO_0032924 | Biological process | activin receptor signaling pathway |
GO_0001837 | Biological process | epithelial to mesenchymal transition |
GO_0007283 | Biological process | spermatogenesis |
GO_0072133 | Biological process | metanephric mesenchyme morphogenesis |
GO_0062009 | Biological process | secondary palate development |
GO_0010666 | Biological process | positive regulation of cardiac muscle cell apoptotic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0060956 | Biological process | endocardial cell differentiation |
GO_0070102 | Biological process | interleukin-6-mediated signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030154 | Biological process | cell differentiation |
GO_0003360 | Biological process | brainstem development |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0007411 | Biological process | axon guidance |
GO_0005634 | Cellular component | nucleus |
GO_0071141 | Cellular component | SMAD protein complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005813 | Cellular component | centrosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0032444 | Cellular component | activin responsive factor complex |
GO_0071144 | Cellular component | heteromeric SMAD protein complex |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005518 | Molecular function | collagen binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0043199 | Molecular function | sulfate binding |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0070412 | Molecular function | R-SMAD binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0031005 | Molecular function | filamin binding |
GO_0070411 | Molecular function | I-SMAD binding |
Gene name | SMAD4 |
Protein name | SMAD4 Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4) Mothers against decapentaplegic homolog (MAD homolog) (Mothers against DPP homolog) (SMAD family member) SMAD family member 4 |
Synonyms | MADH4 DPC4 |
Description | FUNCTION: In muscle physiology, plays a central role in the balance between atrophy and hypertrophy. When recruited by MSTN, promotes atrophy response via phosphorylated SMAD2/4. MSTN decrease causes SMAD4 release and subsequent recruitment by the BMP pathway to promote hypertrophy via phosphorylated SMAD1/5/8. Acts synergistically with SMAD1 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression. Binds to SMAD binding elements (SBEs) (5'-GTCT/AGAC-3') within BMP response element (BMPRE) of cardiac activating regions (By similarity). Common SMAD (co-SMAD) is the coactivator and mediator of signal transduction by TGF-beta (transforming growth factor). Component of the heterotrimeric SMAD2/SMAD3-SMAD4 complex that forms in the nucleus and is required for the TGF-mediated signaling . Promotes binding of the SMAD2/SMAD4/FAST-1 complex to DNA and provides an activation function required for SMAD1 or SMAD2 to stimulate transcription. Component of the multimeric SMAD3/SMAD4/JUN/FOS complex which forms at the AP1 promoter site; required for synergistic transcriptional activity in response to TGF-beta. May act as a tumor suppressor. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator. . |
Accessions | ENST00000589941.2 ENST00000398417.6 ENST00000611848.2 Q13485 K7ENG1 Q9BYG6 ENST00000589076.6 ENST00000593223.2 ENST00000590061.2 K7ELK2 K7EL18 K7EIU8 A0A087WUF3 U6BGT8 ENST00000589076.5 A0A024R274 ENST00000589941.1 K7EIJ2 K7EL15 K7ES96 ENST00000342988.8 ENST00000588860.6 ENST00000590061.1 ENST00000588745.5 ENST00000592186.5 ENST00000588860.5 U6BKH8 |